In the news

Boston Scientific’s new global chief medical officer is already well-known in cardiovascular device space circles. Dr. Ken Stein joined Boston Scientific in 2009 as SVP and chief medical officer of its Rhythm Management business. He became chief medical officer for the entire company on Feb. 13.

Clinical trials are an early step in device and therapy development which have significant impact on the types of products available to patients. Boston Scientific leaders share how the company is working to advance diversity in medical research.

Trevor Boylston had transitioned from female to male a decade before he started working at Boston Scientific. He shares reflections on how navigating the world of work can be enormously challenging for members of the transgender community and how he got involved in the company’s LGBTQ resource group.

Boston Scientific introduced the first U.S. Food and Drug Administration (FDA)-cleared single-use duodenoscope in 2019. Therefore, it is fitting that our first conversation in the Industry Perspective section of iGIE is with Michael Jones, senior vice president and president, Endoscopy for Boston Scientific.

Jenny Dandin is an R&D engineer at Boston Scientific. In a recent telephone interview with Career Communications Group, she shared a unique perspective from her experience as a female making her way as an engineer at a top medical device company.